🇺🇸 FDA
Pipeline program

Buprenorphine

NIDA-06082-4

Approved small_molecule completed

Quick answer

Buprenorphine for Opioid-Related Disorders is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 28 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Opioid-Related Disorders
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials